PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,124,000 | +38.2% | 214,592 | +55.2% | 0.01% | +25.0% |
| Q3 2019 | $3,708,000 | +5.2% | 138,255 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $3,526,000 | +12.2% | 129,976 | +43.5% | 0.00% | +33.3% |
| Q1 2019 | $3,142,000 | +3.1% | 90,547 | +12.2% | 0.00% | 0.0% |
| Q2 2018 | $3,048,000 | +25.6% | 80,698 | +8.6% | 0.00% | +50.0% |
| Q1 2018 | $2,427,000 | -17.8% | 74,315 | +22.5% | 0.00% | -33.3% |
| Q4 2017 | $2,952,000 | +6.3% | 60,648 | +18.1% | 0.00% | 0.0% |
| Q3 2017 | $2,776,000 | -7.2% | 51,373 | -3.5% | 0.00% | 0.0% |
| Q2 2017 | $2,990,000 | +47.2% | 53,240 | +2.7% | 0.00% | +50.0% |
| Q1 2017 | $2,031,000 | +179.8% | 51,833 | +60.1% | 0.00% | +100.0% |
| Q4 2016 | $726,000 | +9.7% | 32,373 | +11.0% | 0.00% | 0.0% |
| Q3 2016 | $662,000 | -34.4% | 29,157 | -31.8% | 0.00% | 0.0% |
| Q2 2016 | $1,009,000 | +1.9% | 42,743 | -11.9% | 0.00% | 0.0% |
| Q1 2016 | $990,000 | -69.6% | 48,534 | -23.3% | 0.00% | -75.0% |
| Q4 2015 | $3,257,000 | +44.9% | 63,305 | +20.1% | 0.00% | +33.3% |
| Q3 2015 | $2,247,000 | +22.1% | 52,725 | +30.4% | 0.00% | +50.0% |
| Q2 2015 | $1,841,000 | +53.8% | 40,418 | +28.2% | 0.00% | +100.0% |
| Q1 2015 | $1,197,000 | +21.4% | 31,522 | -9.5% | 0.00% | 0.0% |
| Q4 2014 | $986,000 | +17.1% | 34,830 | +4.6% | 0.00% | 0.0% |
| Q3 2014 | $842,000 | -8.5% | 33,311 | +5.7% | 0.00% | 0.0% |
| Q2 2014 | $920,000 | – | 31,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|